Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Meets generally accepted scientific standards, well documented and acceptable for assessment. For read across justification please refer to IUCLID chapter 13.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1977
Report date:
1977

Materials and methods

Principles of method if other than guideline:
Method: other: according to H.F. Smyth et al.: Am. Ind. Hyg. Ass. J. 23, 95-107, (1962)
GLP compliance:
no
Test type:
other: Inhalation hazard test
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
N-(2-aminoethyl)-1,3-propanediamine
EC Number:
236-882-0
EC Name:
N-(2-aminoethyl)-1,3-propanediamine
Cas Number:
13531-52-7
Molecular formula:
C5H15N3
IUPAC Name:
N1-(2-Aminoethyl)-1,3-propanediamine
Details on test material:
- Name of test material (as cited in study report): N-Mono(aminopropyl)1,2-diaminoaethan (N-3-Amin)
- Analytical purity: 98 %

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Weight at study initiation: 226 g (mean)

Administration / exposure

Route of administration:
inhalation: vapour
Vehicle:
other: unchanged (no vehicle)
Details on inhalation exposure:
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Temperature in air chamber: 20°C


Duration of exposure:
8 h
No. of animals per sex per dose:
6
Control animals:
not specified
Details on study design:
- Duration of observation period following administration: 1 days

Results and discussion

Effect levels
Dose descriptor:
LC50
Remarks:
calculated saturated vapour concentration
Effect level:
> 0.3 mg/L air
Mortality:
No mortality was observed.
Clinical signs:
other: attempt to escape, closure eyelid, eye irritation
Body weight:
No adverse effects observed
Gross pathology:
Nothing abnormal detected.

Any other information on results incl. tables

-

Applicant's summary and conclusion